Therapeutic Note(s)

Government of Ontario Logo
Notes: Subject to the specific drug's product monograph, for the treatment of schizophrenia and related psychotic disorders after failure, intolerance or contraindication to at least one less expensive antipsychotic alternative. Not indicated for the treatment of dementia or dementia-related behavioral problems in the elderly. Prescribers should be informed and stay current with a drug's official indications in accordance with Health Canada's approved product monograph.